Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cognitive impairment and magnetic resonance imaging correlates in primary progressive multiple sclerosis.
Sparing of tissue by using micro-slit-beam radiation therapy reduces neurotoxicity compared with broad-beam radiation therapy.
Zinc transporter 3 (ZnT3) gene deletion reduces spinal cord white matter damage and motor deficits in a murine MOG-induced multiple sclerosis model.
Guillain Barré Syndrome, Systemic Lupus Erythematosus and Acute Intermittent Porphyria - A Deadly Trio.
Drinking away fatigue in multiple sclerosis.
Evaluation of the Expanded Disability Status Scale and the Multiple Sclerosis Functional Composite as clinical endpoints in multiple sclerosis clinical trials: quantitative meta-analyses.
Ballroom Dance for Persons with Multiple Sclerosis: Physical and Cognitive Efficacy: 2997 Board #62 June 3, 3: 30 PM - 5: 00 PM.
Oligodendrocyte Injury and Pathogenesis of HIV-1-Associated Neurocognitive Disorders.
Prediction of Adiposity by Body Mass Index in Patients With Multiple Sclerosis.
VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
The Association Between Multiple Sclerosis and Uveitis.
Sodium Benzoate, a Food Additive and a Metabolite of Cinnamon, Enriches Regulatory T Cells via STAT6-Mediated Upregulation of TGF-β.
When Evaluating a New Thyroid Mass and a Ring-Enhancing Brain Lesion (When Two Presentations Collide).
Hospitalization, Inpatient burden and comorbidities associated with bullous pemphigoid in the United States.
In vivo modification of tRNA with an artificial nucleobase leads to full disease remission in an animal model of multiple sclerosis.
Diagnosis and Management of Multiple Sclerosis in Children.
Relationship of Obesity With Gait and Balance in People With Multiple Sclerosis.
Autoantibodies against glutamate receptor δ2 after allogenic stem cell transplantation.
Melanocortin-1 receptor activation is neuroprotective in mouse models of neuroinflammatory disease.
Anti-N-methyl-d-aspartate receptor encephalitis in a patient with neuromyelitis optica spectrum disorders.
The progeroid gene BubR1 regulates axon myelination and motor function.
Fampridine and quality of life in individuals with multiple sclerosis.
Gadopentetate but not gadobutrol accumulates in the dentate nucleus of multiple sclerosis patients.
Dimethyl fumarate may still have a role in progressive multiple sclerosis.
Intractable Hiccup in Demyelinating Disease with Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody.
Pages
« first
‹ previous
…
754
755
756
757
758
759
760
761
762
…
next ›
last »